They offer investors very different value propositions.
Abbott Laboratories ( ABT +1.49%) more or less met analyst estimates in its first quarter, the results of which were ...
Whether Abbott Laboratories (NYSE: ABT) stock is at a good entry point depends on your investment horizon and tolerance for ...
The four Cook County cases are being widely watched, with potential implications for both the company and families of babies ...
Investor's Business Daily on MSN
Mesa Laboratories hits 80-plus relative strength rating benchmark
Mesa Laboratories shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 75 to 82.
Abbott Laboratories must pay $53 million in compensatory damages in four cases in which Chicago area babies developed a ...
Abbott Laboratories (NYSE:ABT) reported first-quarter 2026 results that management said were “aligned with our expectations ...
Q1 2026 earnings beat revenue estimates at $11.16B. EPS at $1.15. Exact Sciences acquisition and medical devices fuel results ...
Abbott Laboratories cut its full-year earnings outlook to account for a recent acquisition and said a weaker-than-expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results